Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults

AIDS

Volumn 16, Issue 7, 2002, Pages 1031-1038

  French, Neil ^a   Gray, Katherine ^a   Watera, Christine ^a   Nakiyingi, Jessica ^a   Lugada, Eric ^a   Moore, Michael ^a   Lalloo, David ^a   Whitworth, James A G ^a   Gilks, Charles F ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa; Clinical presentation; Cryptococcal antigen; Cryptococcus; Epidemiology; HIV

Indexed keywords

FUNGUS ANTIGEN;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENINGISM; MIXED INFECTION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; UGANDA;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, FUNGAL; COHORT STUDIES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; PNEUMOCOCCAL VACCINES; RANDOMIZED CONTROLLED TRIALS; SEROEPIDEMIOLOGIC STUDIES; SURVIVAL ANALYSIS; UGANDA;

EID: 0037013093     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200205030-00009     Document Type: Article

References (29)

1. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi
2. The spectrum of meningitis in a population with high prevalence of HIV disease
3. Cryptococcal meningitis in Durban, South Africa: A comparison of clinical features, laboratory findings, and outcome for human immunodeficlency virus (HIV)-positive and HIV-negative patients
4. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe
5. Impact of HIV infection on meningitis in Harare, Zimbabwe: A prospective study of 406 predominantly adult patients
6. AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): Epidemiologic and diagnostic features
7. Bacterial meningitis in Malawian adults: Pneumococcal disease is common, severe, and seasonal
8. Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania
9. Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients ≥ 15 years old, Bangkok
10. Trends in bloodstream infections among human immuno-deficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade
11. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group
12. 3: Demonstration of efficacy in a positive, multicenter trial
13. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection
14. Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model
15. 23-Valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: A double-blind, randomised and placebo controlled trial
16. Proposed 'World Health Organization staging system for HIV infection and disease': Preliminary testing by an international collaborative cross-sectional study
17. Algorithms for detecting antibodies to HIV-1: Results from a rural Ugandan cohort
18. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya
19. Regression models and life tables
20. Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda
21. Cryptococcal infection in an HIV-positive Ugandan population
22. Serum cryptococcal antigen in patients with AIDS
23. Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County
24. Risk factors for cryptococcal meningitis in HIV-infected patients
25. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group
26. Herpes zoster and HIV-1 infection in a rural Ugandan cohort
27. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: Evidence for both local genetic differences and a global clonal population structure